cBioPortal data analysis showed that KBTBD7 is deleted or mutated in a considerable number of prostate, bladder, and uterine cancer patients, further implicating its tumorigenic relevance in other cancer types and suggesting a potential tumor-suppressing function. This evidence concerns the gene KBTBD7 and uterine cancer.